These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 30703284)

  • 1. Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.
    Mu W; Muriello M; Clemens JL; Wang Y; Smith CH; Tran PT; Rowe PC; Francomano CA; Kline AD; Bodurtha J
    Am J Med Genet A; 2019 Apr; 179(4):561-569. PubMed ID: 30703284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
    Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Chuchin JD; Ornstein TJ
    Disabil Rehabil; 2024 Sep; 46(18):4234-4245. PubMed ID: 37843031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity classes in adults with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders: a pilot study of 105 Italian patients.
    Copetti M; Morlino S; Colombi M; Grammatico P; Fontana A; Castori M
    Rheumatology (Oxford); 2019 Oct; 58(10):1722-1730. PubMed ID: 30783660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
    Estrella E; Frazier PA
    Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
    Teran-Wodzinski P; Kumar A
    Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
    Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian validation of the functional difficulties questionnaire (FDQ-9) and its correlation with major determinants of quality of life in adults with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
    Morlino S; Dordoni C; Sperduti I; Clark CJ; Piedimonte C; Fontana A; Colombi M; Grammatico P; Copetti M; Castori M
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jan; 180(1):25-34. PubMed ID: 30471081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective health complaints and illness perception amongst adults with Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-HypermobilityType - a cross-sectional study.
    Hope L; Juul-Kristensen B; Løvaas H; Løvvik C; Maeland S
    Disabil Rehabil; 2019 Feb; 41(3):333-340. PubMed ID: 29041819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.
    Engelbert RH; Juul-Kristensen B; Pacey V; de Wandele I; Smeenk S; Woinarosky N; Sabo S; Scheper MC; Russek L; Simmonds JV
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):158-167. PubMed ID: 28306230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploratory study of clinical characteristics and gait features of adolescents with hypermobility disorders.
    de Koning LE; Scheper MC; Ploeger HE; Warnink-Kavelaars J; Oosterlaan J; Bus SA; Engelbert RHH
    Gait Posture; 2023 Feb; 100():222-229. PubMed ID: 36638668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of pain with gait spatiotemporal parameters in children with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder.
    Jeong HJ; Engel JM; Muriello M; Basel D; Slavens BA
    Gait Posture; 2024 Mar; 109():271-276. PubMed ID: 38368648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome.
    Kalisch L; Hamonet C; Bourdon C; Montalescot L; de Cazotte C; Baeza-Velasco C
    Disabil Rehabil; 2020 Dec; 42(25):3679-3686. PubMed ID: 31060411
    [No Abstract]   [Full Text] [Related]  

  • 16. A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice.
    Feldman ECH; Homan KJ; Williams SE; Ting TV; Goldschneider KR; Kashikar-Zuck S
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):121. PubMed ID: 37845704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Utility of a Patient-Facing Diagnostic Tool Among Individuals With Hypermobile Ehlers-Danlos Syndrome: Focus Group Study.
    Goehringer J; Kosmin A; Laible N; Romagnoli K
    JMIR Form Res; 2024 Sep; 8():e49720. PubMed ID: 39325533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
    Martin A
    Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features that exacerbate fatigue severity in joint hypermobility syndrome/Ehlers-Danlos syndrome - hypermobility type.
    Krahe AM; Adams RD; Nicholson LL
    Disabil Rehabil; 2018 Aug; 40(17):1989-1996. PubMed ID: 28482708
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.